Free Trial
OTCMKTS:SONVY

Sonova (SONVY) Stock Price, News & Analysis

Sonova logo
$73.53 -1.30 (-1.74%)
(As of 11/6/2024 ET)

About Sonova Stock (OTCMKTS:SONVY)

Key Stats

Today's Range
$73.47
$74.08
50-Day Range
$68.08
$77.48
52-Week Range
$48.73
$77.56
Volume
9,614 shs
Average Volume
43,616 shs
Market Capitalization
$21.92 billion
P/E Ratio
N/A
Dividend Yield
0.78%
Price Target
N/A
Consensus Rating
Reduce

Company Overview

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands. The Cochlear Implants segment is involved in the design, development, manufacture, distribution, and service of hearing implants and related products under the Advanced Bionics brand. The company sells its products through independent distributors; and provides hearing care services through a network of stores and clinics. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.

Receive SONVY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sonova and its competitors with MarketBeat's FREE daily newsletter.

SONVY Stock News Headlines

Sonova initiated with a Neutral at Goldman Sachs
Barclays Sticks to Its Hold Rating for Sonova Holding AG (SOON)
The Final Frontier
And a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt to discredit it, tar and feather it, and convince you not to watch it. That’s because it tells the shocking truth about the current AI mania… and why investors in big tech companies like Nvidia, Meta, Alphabet, and Microsoft could be in for a whole world of pain.
Citi Sticks to Its Sell Rating for Sonova Holding AG (SOON)
Sonova Holding AG (SOON) was downgraded to a Hold Rating at Barclays
Barclays Reaffirms Their Buy Rating on Sonova Holding AG (SOON)
Kepler Capital Remains a Sell on Sonova Holding AG (SOON)
Barclays Remains a Buy on Sonova Holding AG (SOON)
See More Headlines

SONVY Stock Analysis - Frequently Asked Questions

Sonova's stock was trading at $65.3250 at the beginning of the year. Since then, SONVY stock has increased by 12.6% and is now trading at $73.53.
View the best growth stocks for 2024 here
.

Shares of SONVY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

Today
11/06/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
OTCMKTS:SONVY
Employees
18,151
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$3.80 billion
Cash Flow
$3.07 per share
Book Value
$9.44 per share

Miscellaneous

Free Float
298,104,000
Market Cap
$21.92 billion
Optionable
Not Optionable
Beta
1.27

Social Links

10 Best Stocks to Own in 2025 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report

This page (OTCMKTS:SONVY) was last updated on 11/7/2024 by MarketBeat.com Staff
From Our Partners